Estimate Recalculated Sep 13, 2024 09:46PM EST
Julian S Gangolli has an estimated net worth of $19.1 Million. This is based on reported shares across multiple companies, which include GW PHARMACEUTICALS PLC, Revance Therapeutics, Inc., Krystal Biotech, Inc., Outlook Therapeutics, Inc., and ALLERGAN INC.
Julian S Gangolli's CIK is 0001532023
2019 was Julian S Gangolli's most active year for acquiring shares with 7 total transactions. Julian S Gangolli's most active month to acquire stocks was the month of April. 2019 was Julian S Gangolli's most active year for disposing of shares, totalling 17 transactions. Julian S Gangolli's most active month to dispose stocks was the month of April. 2014 saw Julian S Gangolli paying a total of $5,093,976.03 for 40,729 shares, this is the most they've acquired in one year. In 2012 Julian S Gangolli cashed out on 180,855 shares for a total of $8,316,023.31, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!